Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Cancer Cachexia (CC) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Cancer Cachexia (CC) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Cancer Cachexia (CC) market report provides current ... Read More
-
Cell And Gene Therapy For Multiple Myeloma – Market Insight, Epidemiology, and Market Forecast – 2034
... an in-depth understanding of the Cell And Gene Therapy For Multiple Myeloma, historical and forecasted epidemiology as well as the Cell And Gene Therapy For Multiple Myeloma market trends in the United States, EU5 (Germany, ... Read More
-
Chronic Myelocytic Leukemia (CML) – Market Insight, Epidemiology, and Market Forecast – 2034
... Myelocytic Leukemia (CML), historical and forecasted epidemiology as well as the Chronic Myelocytic Leukemia (CML) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Chronic Myelocytic Leukemia ... Read More
-
FGFR positive Gastroesophageal Cancer – Market Insight, Epidemiology, and Market Forecast – 2034
... Cancer, historical and forecasted epidemiology as well as the FGFRpositive Gastroesophageal Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The FGFRpositive Gastroesophageal Cancer market report provides ... Read More
-
Metastatic Merkel Cell Carcinoma – Market Insight, Epidemiology, and Market Forecast – 2034
... Merkel Cell Carcinoma, historical and forecasted epidemiology as well as the Metastatic Merkel Cell Carcinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Metastatic Merkel Cell ... Read More
-
Recurrent Head And Neck Cancer Squamous Cell Carcinoma – Market Insight, Epidemiology, and Market Forecast – 2034
... report delivers an in-depth understanding of the Recurrent Head And Neck Cancer Squamous Cell Carcinoma, historical and forecasted epidemiology as well as the Recurrent Head And Neck Cancer Squamous Cell Carcinoma market trends in the ... Read More
-
Relapsed or Refractory Mycosis Fungoides – Market Insight, Epidemiology, and Market Forecast – 2034
... the Relapsed or Refractory Mycosis Fungoides, historical and forecasted epidemiology as well as the Relapsed or Refractory Mycosis Fungoides market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Renal cell carcinoma – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Renal cell carcinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Renal cell carcinoma market report provides current ... Read More
-
Triple-refractory Multiple Myeloma – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Triple-refractory Multiple Myeloma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Triple-refractory Multiple Myeloma market report provides current ... Read More
-
Procarbazine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
... of US$ 102.83 million by 2030 with a CAGR of 3.20% during the forecast period 2024-2030. North American market for Procarbazine was valued at $ 32.71 million in 2023 and will reach $ 40.48 million ... Read More
-
Cancer Anorexia-Cachexia Syndrome (CACS) – Market Insight, Epidemiology, and Market Forecast – 2034
... Anorexia-Cachexia Syndrome (CACS), historical and forecasted epidemiology as well as the Cancer Anorexia-Cachexia Syndrome (CACS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Cancer Anorexia-Cachexia Syndrome ... Read More
-
Follicular Lymphoma – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Follicular Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Follicular Lymphoma market report provides current treatment practices, emerging drugs, Follicular ... Read More
-
Human Papillomavirus 16-positive (HPV16+) Cancers – Market Insight, Epidemiology, and Market Forecast – 2034
... the Human Papillomavirus 16-positive (HPV16+) Cancers, historical and forecasted epidemiology as well as the Human Papillomavirus 16-positive (HPV16+) Cancers market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Lip and Oral Cavity Cancer – Market Insight, Epidemiology, and Market Forecast – 2034
... the Lip and Oral Cavity Cancer, historical and forecasted epidemiology as well as the Lip and Oral Cavity Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Metastatic Urothelial Carcinoma – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Metastatic Urothelial Carcinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Metastatic Urothelial Carcinoma market report provides current ... Read More
-
Muscle Invasive Bladder cancer – Market Insight, Epidemiology, and Market Forecast – 2034
... Invasive Bladder cancer, historical and forecasted epidemiology as well as the Muscle Invasive Bladder cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Muscle Invasive Bladder ... Read More
-
Mycosis Fungoides – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Mycosis Fungoides market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Mycosis Fungoides market report provides current treatment practices, emerging drugs, Mycosis ... Read More
-
Natural Killer (NK)-Cell Lymphoma – Market Insight, Epidemiology, and Market Forecast – 2034
... Killer (NK)-Cell Lymphoma, historical and forecasted epidemiology as well as the Natural Killer (NK)-Cell Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Natural Killer (NK)-Cell ... Read More
-
Soft Tissue Sarcoma – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Soft Tissue Sarcoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Soft Tissue Sarcoma market report provides current ... Read More
-
Uterine Serous Carcinoma – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Uterine Serous Carcinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Uterine Serous Carcinoma market report provides current ... Read More
-
Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) – Market Insight, Epidemiology, and Market Forecast – 2034
... – 2034"" report delivers an in-depth understanding of the Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC), historical and forecasted epidemiology as well as the Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) ... Read More
-
HER2-Negative Breast Cancer – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the HER2-Negative Breast Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The HER2-Negative Breast Cancer market report provides current ... Read More
-
Liver cancer – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Liver cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Liver cancer market report provides current treatment practices, emerging drugs, Liver ... Read More
-
Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) – Market Insight, Epidemiology, and Market Forecast – 2034
... – 2034"" report delivers an in-depth understanding of the Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC), historical and forecasted epidemiology as well as the Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) ... Read More
-
Checkpoint Inhibitor Refractory Cancer – Market Insight, Epidemiology, and Market Forecast – 2034
... Inhibitor Refractory Cancer, historical and forecasted epidemiology as well as the Checkpoint Inhibitor Refractory Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Checkpoint Inhibitor Refractory ... Read More
Research Assistance
